SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Politics for Pros- moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: grusum who wrote (722729)8/2/2020 10:48:56 AM
From: skinowski2 Recommendations

Recommended By
i-node
pak73

  Read Replies (3) of 794002
 
Ivermectin is excreted unchanged, or metabolized in the liver. Hardly any impact on the kidneys.

This article has some interesting stories about practical experience with Ivermectin for CoViD:

trialsitenews.com

Sounds interesting. Personally, the way things stand now, I think HCQ is a better choice - there is more experience with using it, more studies. At this point, I’d consider using Ivermectin if it looks like HCQ is ineffective (or, failed as a prophylactic medication), or if a person for some reason cannot tolerate HCQ.

This will probably change as more info comes out.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News